Skip to content

Cardinal Health

NYSE: CAH · USD

Cardinal Health cash flow and EPS—

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$2,532M
Cardinal Health capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2010 Q12.92% · $37M2.52% · $32M0% · $0M5.06% · $64.2M89.49% · $1,134.4M100% · $1,267.6M
FY 2010 Q28.47% · $42.9M0% · $0M9.87% · $50M12.44% · $63M69.21% · $350.5M100% · $506.4M
FY 2010 Q349.44% · $61.9MUnavailable0% · $0M50.32% · $63M0.24% · $0.3M100% · $125.2M
FY 2010 Q431.57% · $118.2M3.42% · $12.8M48.13% · $180.2M16.8% · $62.9M0.08% · $0.3M100% · $374.4M
FY 2011 Q16.44% · $62M58.18% · $559.9M28.03% · $269.8M7.3% · $70.3M0.04% · $0.4M100% · $962.4M
FY 2011 Q23.42% · $64.1M92.49% · $1,735.1M0% · $0M3.61% · $67.7M0.48% · $9M100% · $1,875.9M
FY 2011 Q317.29% · $59.9M0% · $0M0% · $0M19.6% · $67.9M63.12% · $218.7M100% · $346.5M
FY 2011 Q458.96% · $105.3M2.52% · $4.5M0% · $0M38.24% · $68.3M0.28% · $0.5M100% · $178.6M
FY 2012 Q110.32% · $44.3M1.7% · $7.3M69.88% · $300M17.98% · $77.2M0.12% · $0.5M100% · $429.3M
FY 2012 Q243.21% · $57M0% · $0M0% · $0M56.41% · $74.4M0.38% · $0.5M100% · $131.9M
FY 2012 Q318.56% · $57.7M43.53% · $135.3M0% · $0M23.91% · $74.3M14% · $43.5M100% · $310.8M
FY 2012 Q418.37% · $104M5.55% · $31.4M26.5% · $150M13.09% · $74.1M36.48% · $206.5M100% · $566M
FY 2013 Q16.28% · $26M24.15% · $100M48.31% · $200M20.29% · $84M0.97% · $4M100% · $414M
FY 2013 Q224.83% · $36M17.93% · $26M0% · $0M55.86% · $81M1.38% · $2M100% · $145M
FY 2013 Q31.84% · $41M93.98% · $2,093M0% · $0M4.18% · $93M0% · $0M100% · $2,227M
FY 2013 Q412.17% · $92M2.65% · $20M33.07% · $250M12.57% · $95M39.55% · $299M100% · $756M
FY 2014 Q112.62% · $26M12.14% · $25M24.27% · $50M50.97% · $105M0% · $0M100% · $206M
FY 2014 Q233.16% · $64M12.95% · $25M0% · $0M53.37% · $103M0.52% · $1M100% · $193M
FY 2014 Q37.88% · $48M19.38% · $118M55.67% · $339M17.08% · $104M0% · $0M100% · $609M
FY 2014 Q413.06% · $111M41.29% · $351M33.41% · $284M12.12% · $103M0.12% · $1M100% · $850M
FY 2015 Q16.25% · $36M10.59% · $61M62.5% · $360M20.66% · $119M0% · $0M100% · $576M
FY 2015 Q22.71% · $47M1.44% · $25M18.82% · $326M6.58% · $114M70.44% · $1,220M100% · $1,732M
FY 2015 Q313.9% · $56M57.82% · $233M0% · $0M28.04% · $113M0.25% · $1M100% · $403M
FY 2015 Q419.68% · $161M23.59% · $193M42.79% · $350M13.94% · $114M0% · $0M100% · $818M
FY 2016 Q15.13% · $83M86.52% · $1,399M0% · $0M8.1% · $131M0.25% · $4M100% · $1,617M
FY 2016 Q24.37% · $92M89.55% · $1,885M0% · $0M6.08% · $128M0% · $0M100% · $2,105M
FY 2016 Q317.14% · $109M15.57% · $99M47.17% · $300M19.97% · $127M0.16% · $1M100% · $636M
FY 2016 Q420.34% · $181M25.96% · $231M39.44% · $351M14.16% · $126M0.11% · $1M100% · $890M
FY 2017 Q119.65% · $100M1.77% · $9M49.12% · $250M29.27% · $149M0.2% · $1M100% · $509M
FY 2017 Q216.92% · $113M0.3% · $2M52.4% · $350M21.56% · $144M8.83% · $59M100% · $668M
FY 2017 Q324.69% · $80M31.48% · $102M0% · $0M43.83% · $142M0% · $0M100% · $324M
FY 2017 Q418.61% · $94M3.76% · $19M0% · $0M28.12% · $142M49.5% · $250M100% · $505M
FY 2018 Q10.97% · $67M88.87% · $6,139M2.17% · $150M2.17% · $150M5.82% · $402M100% · $6,908M
FY 2018 Q240.4% · $101M0.8% · $2M0% · $0M58.4% · $146M0.4% · $1M100% · $250M
FY 2018 Q315.03% · $78M0.19% · $1M57.8% · $300M26.97% · $140M0% · $0M100% · $519M
FY 2018 Q414.78% · $138M0% · $0M10.71% · $100M15.52% · $145M58.99% · $551M100% · $934M
FY 2019 Q17.17% · $58M0% · $0M74.17% · $600M18.54% · $150M0.12% · $1M100% · $809M
FY 2019 Q226.01% · $58M9.42% · $21M0% · $0M64.13% · $143M0.45% · $1M100% · $223M
FY 2019 Q332.2% · $76M7.2% · $17M0% · $0M60.17% · $142M0.42% · $1M100% · $236M
FY 2019 Q49.57% · $136M3.1% · $44M0% · $0M9.99% · $142M77.34% · $1,099M100% · $1,421M
FY 2020 Q111.21% · $72MUnavailable54.52% · $350M22.74% · $146M11.53% · $74M100% · $642M
FY 2020 Q28.22% · $77MUnavailable0% · $0M15.05% · $141M76.73% · $719M100% · $937M
FY 2020 Q327.61% · $90M0% · $0M0% · $0M43.25% · $141M29.14% · $95M100% · $326M
FY 2020 Q417.26% · $136M0% · $0M0% · $0M17.89% · $141M64.85% · $511M100% · $788M
FY 2021 Q129.55% · $78MUnavailable0% · $0M55.3% · $146M15.15% · $40M100% · $264M
FY 2021 Q238.71% · $96MUnavailable0% · $0M57.66% · $143M3.63% · $9M100% · $248M
FY 2021 Q322.37% · $100M0% · $0M44.74% · $200M31.99% · $143M0.89% · $4M100% · $447M
FY 2021 Q416.07% · $126M0% · $0M0% · $0M17.98% · $141M65.94% · $517M100% · $784M
FY 2022 Q15.14% · $67MUnavailable38.37% · $500M11.44% · $149M45.05% · $587M100% · $1,303M
FY 2022 Q214.26% · $74MUnavailable57.8% · $300M26.97% · $140M0.96% · $5M100% · $519M
FY 2022 Q319.39% · $82M0% · $0M47.28% · $200M32.15% · $136M1.18% · $5M100% · $423M
FY 2022 Q426.97% · $164M3.62% · $22M0% · $0M22.04% · $134M47.37% · $288M100% · $608M
FY 2023 Q15.74% · $70MUnavailable82.03% · $1,000M11.65% · $142M0.57% · $7M100% · $1,219M
FY 2023 Q218.09% · $85MUnavailable53.19% · $250M27.45% · $129M1.28% · $6M100% · $470M
FY 2023 Q310.43% · $109MUnavailable23.92% · $250M12.25% · $128M53.4% · $558M100% · $1,045M
FY 2023 Q425.5% · $217M0% · $0M58.75% · $500M14.81% · $126M0.94% · $8M100% · $851M
FY 2024 Q112.6% · $92MUnavailable68.49% · $500M17.95% · $131M0.96% · $7M100% · $730M
FY 2024 Q222.98% · $114MUnavailable50.4% · $250M25% · $124M1.61% · $8M100% · $496M
FY 2024 Q37.81% · $112M83.12% · $1,192M0% · $0M8.51% · $122M0.56% · $8M100% · $1,434M
FY 2024 Q417.95% · $193MUnavailable0% · $0M11.35% · $122M70.7% · $760M100% · $1,075M
FY 2025 Q114.95% · $90M0% · $0M62.29% · $375M21.26% · $128M1.5% · $9M100% · $602M
FY 2025 Q25.74% · $99M62.34% · $1,076M0.87% · $15M7.07% · $122M23.99% · $414M100% · $1,726M
FY 2025 Q33.69% · $126M81.38% · $2,779M10.98% · $375M3.63% · $124M0.32% · $11M100% · $3,415M
FY 2025 Q413.2% · $232M79.35% · $1,395M0% · $0M6.83% · $120M0.63% · $11M100% · $1,758M
FY 2026 Q19.27% · $108M3.52% · $41M32.19% · $375M11.07% · $129M43.95% · $512M100% · $1,165M
FY 2026 Q25.17% · $131M74.41% · $1,884M15.13% · $383M4.82% · $122M0.47% · $12M100% · $2,532M
Sep 30, 2009 through Jun 30, 2026

Operating cash flow

USD millions

$686M

Capital expenditures

USD millions

$131M

Free cash flow

USD millions

$555M

Stock-based compensation

USD millions

$87M

SBC / free cash flow

% · FCF before SBC deduction

15.68%

SBC / operating cash flow

%

12.68%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

—

Quarterly data

Cardinal Health cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Dec 31, 20256861315558715.68%12.68%——
FY 2026 Q1Sep 30, 20259731088659310.75%9.56%—$1.88
FY 2025 Q4Jun 30, 20251,5272321,29515311.81%10.02%——
FY 2025 Q3Mar 31, 20252,9171262,791311.11%1.06%——
FY 2025 Q2Dec 31, 2024-40099-49930————
FY 2025 Q1Sep 30, 2024-1,64790-1,73730———$1.7
FY 2024 Q4Jun 30, 20242,0771931,884331.75%1.59%——
FY 2024 Q3Mar 31, 2024-49112-16131———$1.07
FY 2024 Q2Dec 31, 20231,1891141,075282.6%2.35%—$1.5
FY 2024 Q1Sep 30, 202354592453296.4%5.32%—$0.02
FY 2023 Q4Jun 30, 2023858217641274.21%3.15%——
FY 2023 Q3Mar 31, 20231,3611091,252211.68%1.54%—$1.41
FY 2023 Q2Dec 31, 202259785512254.88%4.19%—$-0.3
FY 2023 Q1Sep 30, 20222370-4723—100%—$0.4
FY 2022 Q4Jun 30, 20222,9921642,828160.57%0.53%——
FY 2022 Q3Mar 31, 2022-41982-50123————
FY 2022 Q2Dec 31, 20211,195741,121181.61%1.51%——
FY 2022 Q1Sep 30, 2021-64667-71324———$0.94
FY 2021 Q4Jun 30, 202166512653950.93%0.75%——
FY 2021 Q3Mar 31, 20212771001773318.64%11.91%——
FY 2021 Q2Dec 31, 20201,217961,121232.05%1.89%——
FY 2021 Q1Sep 30, 2020270781922814.58%10.37%—$-0.86
FY 2020 Q4Jun 30, 20202401361042221.15%9.17%——
FY 2020 Q3Mar 31, 20201,676901,586271.7%1.61%——
FY 2020 Q2Dec 31, 201969777620213.39%3.01%——
FY 2020 Q1Sep 30, 2019-65372-72520———$-16.65
FY 2019 Q4Jun 30, 2019506136370184.86%3.56%——
FY 2019 Q3Mar 31, 20191,480761,404231.64%1.55%——
FY 2019 Q2Dec 31, 201837158313227.03%5.93%——
FY 2019 Q1Sep 30, 201836558307196.19%5.21%—$1.94
FY 2018 Q4Jun 30, 2018554138416215.05%3.79%——
FY 2018 Q3Mar 31, 201875478676243.55%3.18%——
FY 2018 Q2Dec 31, 20172791011782312.92%8.24%——
FY 2018 Q1Sep 30, 20171,181671,114171.53%1.44%——
FY 2017 Q4Jun 30, 201772494630233.65%3.18%——
FY 2017 Q3Mar 31, 2017-19880-27826————
FY 2017 Q2Dec 31, 2016554113441245.44%4.33%——
FY 2017 Q1Sep 30, 2016104100423575%22.12%——
FY 2016 Q4Jun 30, 2016641181460296.3%4.52%——
FY 2016 Q3Mar 31, 2016919109810263.21%2.83%—$1.17
FY 2016 Q2Dec 31, 20151,463921,371261.9%1.78%—$0.98
FY 2016 Q1Sep 30, 2015-5283-13530———$1.15
FY 2015 Q4Jun 30, 2015868161707304.24%3.46%——
FY 2015 Q3Mar 31, 201565856602274.49%4.1%—$1.09
FY 2015 Q2Dec 31, 201495347906283.09%2.94%—$0.86
FY 2015 Q1Sep 30, 201461362525100%40.98%—$0.78
FY 2014 Q4Jun 30, 2014716111605243.97%3.35%——
FY 2014 Q3Mar 31, 201482048772243.11%2.93%—$0.91
FY 2014 Q2Dec 31, 20133764-2724—64.86%—$0.8
FY 2014 Q1Sep 30, 201395126925242.59%2.52%—$0.99
FY 2013 Q4Jun 30, 2013300922082512.02%8.33%——
FY 2013 Q3Mar 31, 201398941948222.32%2.22%—$1
FY 2013 Q2Dec 31, 2012-13036-16622———$0.88
FY 2013 Q1Sep 30, 201256826542244.43%4.23%—$0.79
FY 2012 Q4Jun 30, 2012-106.9104-210.921.9————
FY 2012 Q3Mar 31, 2012893.257.7835.521.62.59%2.42%—$0.95
FY 2012 Q2Dec 31, 2011-114.557-171.521.7———$0.75
FY 2012 Q1Sep 30, 2011504.244.3459.919.84.31%3.93%—$0.68
FY 2011 Q4Jun 30, 2011119.8105.314.519.1131.72%15.94%—$0.58
FY 2011 Q3Mar 31, 201191459.9854.1182.11%1.97%—$0.7
FY 2011 Q2Dec 31, 2010143.864.179.72126.35%14.6%—$0.61
FY 2011 Q1Sep 30, 20102176215521.413.81%9.86%—$0.84
FY 2010 Q4Jun 30, 2010324.2118.220620.59.95%6.32%—$0.54
FY 2010 Q3Mar 31, 2010879.361.9817.436.94.51%4.2%—$0.61
FY 2010 Q2Dec 31, 2009524.642.9481.720.14.17%3.83%—$0.65
FY 2010 Q1Sep 30, 200940637369225.96%5.42%—$-0.11
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · CAH, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.